STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ACCURAY INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Accuray Inc. (ARAY) director reports equity transactions in a Form 4. On 11/21/2025, the director settled 56,603 restricted stock units (RSUs), receiving the same number of shares of Accuray common stock at an exercise price of $0. On the same date, 22,642 shares of common stock were disposed of at $1.05 per share, described as shares forfeited due to a cash settlement election made in the grant agreement. After these transactions, the director beneficially owned 153,294 shares of Accuray common stock, held directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scott Byron C

(Last) (First) (Middle)
1240 DEMING WAY

(Street)
MADISON WI 53717

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACCURAY INC [ ARAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/21/2025 M 56,603 A $0 175,936 D
Common Stock 11/21/2025 F 22,642(1) D $1.05 153,294 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units(2) $0 11/21/2025 M 56,603 (3) (3) Common Stock 56,603 $0 0 D
Explanation of Responses:
1. These shares were forfeited due to a cash settlement election made by the director in the grant agreement.
2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
3. This represents a Restricted Stock Unit that vests 100% on 11/21/2025.
Remarks:
/s/ Michael Stetler, Power of Attorney for Byron C Scott 11/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What type of SEC filing did Accuray Inc. (ARAY) report in this document?

This document is a Form 4, which reports changes in the beneficial ownership of Accuray Inc. (ARAY) securities by an insider, in this case a director of the company.

What equity transactions did the Accuray (ARAY) director report on 11/21/2025?

On 11/21/2025, the director reported acquiring 56,603 shares of Accuray common stock at $0 through the settlement of restricted stock units, and disposing of 22,642 shares at $1.05 per share.

How many Accuray (ARAY) shares does the director own after these Form 4 transactions?

Following the reported transactions, the director beneficially owns 153,294 shares of Accuray Inc. common stock, held in direct ownership.

What are the terms of the restricted stock units (RSUs) reported in the Accuray (ARAY) Form 4?

Each RSU represents a contingent right to receive one share of Accuray common stock. The RSU grant referenced in this Form 4 covered 56,603 units and vests 100% on 11/21/2025 at an exercise price of $0.

Why were 22,642 Accuray (ARAY) shares forfeited by the director?

The Form 4 notes that the 22,642 shares were forfeited due to a cash settlement election made by the director in the RSU grant agreement.

What is the director’s relationship to Accuray Inc. (ARAY) as disclosed in the Form 4?

The reporting person is identified as a director of Accuray Inc., as indicated in the relationship section of the Form 4.
Accuray Incorp

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Latest SEC Filings

ARAY Stock Data

117.87M
109.35M
2.06%
71.26%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MADISON